Nature
Volume 602 Issue 7898, 24 February 2022
https://www.nature.com/nature/volumes/602/issues/7898

Article | 23 December 2021 | Open Access
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
A high-throughput yeast display platform is used to analyse the profiles of mutations in the SARS-CoV-2 receptor-binding domain (RBD) that enable escape from antibodies, and suggests that most anti-RBD antibodies can be escaped by the Omicron variant.
Yunlong Cao, Jing Wang, Xiaoliang Sunney Xie